Single-centre experience with the Thoratec® paracorporeal ventricular assist device for patients with primary cardiac failure

Archives of Cardiovascular Diseases

Volumn 102, Issue 6-7, 2009, Pages 509-518

  Kirsch, Matthias ^a   Vermes, Emmanuelle ^a   Damy, Thibaud ^a   Nakashima, Kuniki ^a   Sénéchal, Mélanie ^a   Boval, Bernadette ^b   Drouet, Ludovic ^b   Loisance, Daniel ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cardiogenic shock; Mechanical circulatory support; Survival; Ventricular assist devices

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIOGENIC SHOCK; EQUIPMENT DESIGN; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; EQUIPMENT DESIGN; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PATIENT ADMISSION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SHOCK, CARDIOGENIC; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73349140879     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2009.03.010     Document Type: Article

References (25)

1. Hill JD, Farrar DJ, Naka Y, Chen JM, Portner PM, Loisance D. Positive displacement ventricular assist devices. ISHLT Monograph Series 2006;1:53-75.
2. Hoefer D, Ruttmann E, Poelzl G, et al. Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg 2006;82:28-33.
3. Morgan JA, Stewart AS, Lee BJ, Oz MC, Naka Y. Role of the Abiomed BVS 5000 device for short-term support and bridge to transplantation. ASAIO J 2004;50:360-3. (Pubitemid 38917884)
4. John R, Liao K, Lietz K, et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 2007;134: 351-8. (Pubitemid 47088583)
5. Thiele H, Smalling RW, Schuler GC. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2007;28: 2057-63. (Pubitemid 47517433)
6. Houel R, Mazoyer E, Boval B, et al. Platelet activation and aggregation profile in prolonged external ventricular support. J Thorac Cardiovasc Surg 2004;128:197-202. (Pubitemid 38969800)
7. Deng MC, Edwards LB, Hertz MI, Rowe AW, Kormos RL. Mechanical Circulatory Support Device database of the International Society for Heart and Lung Transplantation: first annual report 2003. J Heart Lung Transplant 2003;22:653-62. (Pubitemid 36773677)
8. McBride LR, Naunheim KS, Fiore AC, Moroney DA, Swartz MT. Clinical experience with 111 Thoratec ventricular assist devices. Ann Thorac Surg 1999;67:1233-8 [discussion 1238-9]. (Pubitemid 29320206)
9. Minami K, El-Banayosy A, Sezai A, et al. Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor, and HeartMate for bridging to heart transplantation. Artif Organs 2000;24:421-6. (Pubitemid 30430500)
10. El-Banayosy A, Arusoglu L, Kizner L, et al. Predictors of survival in patients bridged to transplantation with the Thoratec VAD device: a single-center retrospective study on more than 100 patients. J Heart Lung Transplant 2000;19: 964-8.
11. Farrar DJ. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant 1994;13:93-100 [discussion 100-1].
12. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003;125:855-62. (Pubitemid 36457507)
13. Kirsch M, Vermes E, Radu C, et al. Impact of preoperative hemodynamic support on early outcome in patients assisted with paracorporeal Thoratec ventricular assist device. Eur J Cardiothorac Surg 2008;34:262-7.
14. De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J 2004;147:91-9. (Pubitemid 38037403)
15. Baba A, Dobsak P, Saito I, et al. Microcirculation of the bulbar conjunctiva in the goat implanted with a total artificial heart: effects of pulsatile and nonpulsatile flow. ASAIO J 2004;50:321-7. (Pubitemid 38917878)
16. Orime Y, Shiono M, Nakata K, et al. The role of pulsatility in end-organ microcirculation after cardiogenic shock. ASAIO J 1996;42:M724-9. (Pubitemid 26363761)
17. Sezai A, Shiono M, Orime Y, et al. Major organ function under mechanical support: comparative studies of pulsatile and non-pulsatile circulation. Artif Organs 1999;23:280-5. (Pubitemid 29147183)
18. Ochiai Y, McCarthy PM, Smedira NG, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002;106:I198-202.
19. Farrar DJ, Hill JD, Pennington DG, et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1997;113:202-9. (Pubitemid 27034359)
20. Kormos RL, Gasior TA, Kawai A, et al. Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 1996;111:773-82 [discussion 782-3].
21. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a preoperative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008;51: 2163-72. (Pubitemid 351713685)
22. Deng MC, Loebe M, El-Banayosy A, et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 2001;103:231-7. (Pubitemid 32095408)
23. Schenk S, McCarthy PM, Blackstone EH, et al. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. J Thorac Cardiovasc Surg 2006;131:447-54. (Pubitemid 43121570)
24. Magliato KE, Kleisli T, Soukiasian HJ, et al. Biventricular support in patients with profound cardiogenic shock: a single-center experience. ASAIO J 2003;49:475-9. (Pubitemid 36898991)
25. Tsukui H, Teuteberg JJ, Murali S, et al. Biventricular assist device utilization for patients with morbid congestive heart failure: a justifiable strategy. Circulation 2005;112: 165-72.